Brain/Spinal Cord Cancers
Chemotherapy Plus Chemoprotected Autologous Stem Cells for Malignant Gliomas (FHCRC-2000)
Dose-Intensive Chemotherapy in Combination with Chemoprotected Autologous Stem Cells for Patients with Malignant Gliomas
Investigator: Hans-Peter Kiem, MD; Conditions: Brain Cancer; Glioma; Solid Tumors; Status: Recruiting; Study ID: NCT00669669
Phase II Trial of Observation for Low-Risk Meningiomas and of Radiotherapy for Intermediate- and High-Risk Meningiomas Researchers
Investigator: George Laramore, MD; Conditions: Brain and Central Nervous System Tumors; Status: Recruiting; Study ID: NCT00895622
Phase III Study of Radiation Therapy With or Without Temozolomide For Symptomatic or Progressive Low-Grade Gliomas CCIRB#7269
Investigator: George Laramore, MD; Conditions: Brain and Central Nervous System Tumors, Neurotoxicity Syndromes; Status: Recruiting; Study ID: NCT00978458
Randomized, Phase II, Double-Blind, Placebo-Controlled Trial of Conventional Chemoradiation and Adjuvant Temozolomide Plus Cediranib Versus Conventional Chemoradiation and Adjuvant Temozolomide Plus Placebo in Patients with Newly Diagnosed Glioblastoma
Investigator: George Laramore, MD; Conditions: Brain and Central Nervous System Tumors; Status: Temporarily Suspended; Study ID: NCT01062425
A Phase 1 and 2 Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain
Investigator: Daniel Silbergeld; Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Mixed Glioma, Recurrent Adult Brain Tumor; Status: Closed; Study ID: NCT01148966
Join Us On